Published in Cornea on March 01, 2002
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med (2004) 4.77
Ocular immune privilege. Eye (Lond) (2009) 1.45
Natural killer cells in rejection and tolerance of solid organ allografts. Curr Opin Organ Transplant (2011) 0.84
Ocular immune privilege in the year 2010: ocular immune privilege and uveitis. Ocul Immunol Inflamm (2010) 0.81
Ocular Immune Privilege and Transplantation. Front Immunol (2016) 0.80
Non-specific tolerance induced by staphylococcal enterotoxin B in treating high risk corneal transplantation in rats. Br J Ophthalmol (2005) 0.79
Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis. Clin Exp Immunol (2014) 0.76
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest (2005) 3.77
Retracted Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth. J Exp Med (2011) 3.15
Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J Immunol (2004) 2.50
The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med (2005) 1.85
CD4+ NKT cells, but not conventional CD4+ T cells, are required to generate efferent CD8+ T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol (2003) 1.25
CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur J Immunol (2002) 1.18
NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol (2002) 1.17
Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol (2002) 1.10
Invariant NKT cells and tolerance. Int Rev Immunol (2007) 1.01
Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells. Invest Ophthalmol Vis Sci (2006) 0.99
Using tolerance induced via the anterior chamber of the eye to inhibit Th2-dependent pulmonary pathology. J Immunol (2002) 0.93
History and physiology of immune privilege. Ocul Immunol Inflamm (2010) 0.92
Therapies based on principles of ocular immune privilege. Chem Immunol Allergy (2007) 0.87
B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest Ophthalmol Vis Sci (2006) 0.86
Retinal laser burn disrupts immune privilege in the eye. Am J Pathol (2009) 0.85
Tolerogenic APC generate CD8+ T regulatory cells that modulate pulmonary interstitial fibrosis. J Immunol (2004) 0.85
F4/80: the macrophage-specific adhesion-GPCR and its role in immunoregulation. Adv Exp Med Biol (2010) 0.85
CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance. Invest Ophthalmol Vis Sci (2006) 0.84
NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye. J Immunol (2007) 0.84
Modulation of ovalbumin-induced airway inflammation and hyperreactivity by tolerogenic APC. J Immunol (2005) 0.82
Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege. J Immunol (2012) 0.79
Mechanisms of peripheral tolerance following intracameral inoculation are independent of IL-13 or STAT6. J Immunol (2005) 0.77